The European Commission approved Johnson and Johnson’s Yuvanci as the first single-pill combination therapy for PAH.

Cognitive decline may increase an older person's risk for a fall, while the trauma that follows a fall may also speed up ...

The U.S.Centers for Disease Control and Prevention on Monday said it was in conversation with Rwandan health officials amid ...

The University of the Philippines Manila has developed a medicine for type 2 diabetes, which has shown therapeutic effect on ...

It is not the strongest of the species that survives, nor the most intelligent, but the one most responsive to change.” – ...

MDMA-assisted psychotherapy has been shown to be a safe and effective treatment for PTSD and complex trauma. Why did the FDA ...

Louisiana will become the first in the United States on Tuesday to categorize two widely used abortion-inducing pills as ...

The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.

The Federal Circuit has vacated a District of Delaware ruling in a patent case which found that patent claims asserted by ...

Motiva is the first new breast implant to receive premarket approval since 2013, according to Establishment Labs, and enters ...

Innovative technology incorporated in Nanoscope’s gene therapy offers hope for restoring vision in genetically caused visual ...